Key result
Among 2205 cardiac arrhythmia and heart failure patients in India, 46% were potential device/RFA candidates, but 83% of these indicated patients were not advised therapy or did not opt for it.
Observational (n=2,205)
Yes
There is a massive gap in the referral and uptake of guideline-indicated device and ablation therapies for arrhythmia and heart failure patients in India.
Reveals large referral/uptake gaps for device/RFA in Indian arrhythmia/HF patients; leaves open drivers of and solutions to this disparity.
BACKGROUND: The PANARrhythMia and Heart Failure Registry (PANARM HF) characterized demographic, clinical and interventional therapy indication profiles of cardiac arrhythmia (CA) and heart failure (HF) patients in India. METHODS: Consulting Physicians (CP) who medically manage CA and HF patients enrolled patients with one or more of the following: syncope, pre-syncope, dyspnea, palpitation, fatigue and LV dysfunction. The CPs were trained by interventional cardiologists (IC) to identify CA/HF patients indicated for implantable device/radiofrequency ablation (RFA). 59 CP's, 16 IC's & 2205 patients from 12 cities participated. Demographic, clinical, device/RFA indication and referral-consultation profiles were created. IC's provided device/RFA recommendations based on these profiles. RESULTS: The CA/HF distribution of patients was: HF - 58%, bradyarrhythmia - 15%, atrial fibrillation - 15%, other supraventricular tachyarrhythmia - 10% and ventricular tachycardia/fibrillation - 4.5%. 62% of the CA/HF population was male and 45% were below age 60. Coronary artery disease (52%), hypertension (44%), diabetes (30%) & myocardial infarction (20%) were prominent. 1011 (46%) of the CA/HF population were potential device/RFA candidates according to the IC's. However, only 700 (69%) of these patients were referred to the IC by the CP. Of referred patients, only 177 (25%) consulted the IC and were recommended therapy. Thus, 824 (83%) of patients indicated for interventional therapy were not advised therapy or did not opt for it. CONCLUSION: The India PANARM HF study provides new information and insights into the demographic, clinical, interventional therapy, referral and consultation pattern profiles of CA/HF patients in India.
No takes yet. Share an insight, caveat, or question.
Vora et al. (2017) conducted an observational in Cardiac arrhythmia and heart failure (n=2,205). Among 2205 cardiac arrhythmia and heart failure patients in India, 46% were potential device/RFA candidates, but 83% of these indicated patients were not advised therapy or did not opt for it.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: